Mots-clés
> MYOBASE > SANTE > médecine > maladie > pathologie > évolution de la maladie > complication de la maladie
complication de la maladieSynonyme(s)maladie compliquée ;complicated disease disease complications |
Documents disponibles dans cette catégorie (871)
Article
Article
Article
van den Bersselaar LR ; Gubbels M ; Riazi S ; Heytens L ; Jungbluth H ; Voermans NC ; Snoeck MMJ | United States | 23/03/2022Article
Gragnaniello V ; Deodato F ; Gasperini S ; Donati MA ; Canessa C ; Fecarotta S ; Pascarella A ; Spadaro G ; Concolino D ; Burlina A ; Parenti G ; Strisciuglio P ; Fiumara A ; Casa RD | 05/03/2022Article
Maresh K ; Papageorgiou A ; Ridout D ; Harrison NA ; Mandy W ; Skuse D ; Muntoni F | England | 08/02/2022Article
Initial Posting: September 5, 2000; Last Revision: January 20, 2022. Clinical characteristics. The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker[...]Article
Yoshioka W ; Shimizu R ; Takahashi Y ; Oda Y ; Yoshida S ; Ishihara N ; Nishino I ; Nakamura H ; Mori Yoshimura M | Netherlands | 01/2022Article
Abicht A ; Müller J ; Lochmuller H | 23/12/2021Initial Posting: May 9, 2003; Last Update: December 23, 2021. The purpose of this overview is to increase the awareness of clinicians regarding congenital myasthenic syndromes (CMS) and their genetic causes and management. The following ar[...]Article
Lanot N ; Vincenti M ; Abassi H ; Bredy C ; Agullo A ; Gamon L ; Mura T ; Lavastre K ; De La Villeon G ; Barrea C ; Meyer P ; Rivier F ; Meli AC ; Fauconnier J ; Cazorla O ; Lacampagne A ; Amedro P | United States | 14/12/2021Article
Article
Article
Article
Article
Article
Article
Article
Article
Last Update: July 8, 2021. (previous version July 8, 2021)Article
Article
Last Update: July 7, 2021. [Previous update: February 13, 2021]Article
Article
Kichula EA ; Proud CM ; Farrar MA ; Kwon JM ; Saito K ; Desguerre I ; McMillan HJ | United States | 30/06/2021Article
Article
Spiritovic M ; Hermankova B ; Oreska S ; Storkanova H ; Ruzickova O ; Vernerova L ; Klein M ; Kubinova K ; Smucrova H ; Rathouska A ; Cesak P ; Komarc M ; Bunc V ; Pavelka K ; Senolt L ; Mann H ; Vencovsky J ; Tomcik M | 21/06/2021Article
Article
Dermatomyositis is a rare acquired immune-mediated muscle disease characterized by muscle weakness and skin rash. It is classified as one of the idiopathic inflammatory myopathies (IIM). Although all idiopathic inflammatory myopathies share the [...]Article
Rietveld A ; van Gaalen J ; Saris C ; Okkersen K ; Kusters B ; van de Warrenburg B ; van Engelen B ; Sacconi S ; Raaphorst J | England | 06/2020Article
Rodolico C ; Politano L ; Portaro S ; Murru S ; Boccone L ; Sera F ; Passamano L ; Brizzi T ; Tupler R | England | 05/2020Article
Article
Chung MP ; Richardson C ; Kirakossian D ; Orandi AB ; Saketkoo LA ; Rider LG ; Schiffenbauer A ; von Muhlen CA ; Chung L | Netherlands | 03/2020Article
Article
Article
Wittlieb Weber CA ; Knecht KR ; Villa CR ; Cunningham C ; Conway J ; Bock MJ ; Gambetta KE ; Lal AK ; Schumacher KR ; Law SP ; Deshpande SR ; West SC ; Friedland Little JM ; Lytrivi ID ; McCulloch MA ; Butts RJ ; Weber DR ; Johnson JN | United States | 02/2020Article
Rosenberg H ; Sambuughin N ; Riazi S ; Dirksen R | 16/01/2020Initial Posting: December 19, 2003; Last Update: January 16, 2020. Clinical characteristics. Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeleta[...]Article
Gutierrez Ruiz C ; Mateu Arrom L ; Mayordomo O ; Martinez Barea V ; Palou Redorta J ; Errando Smet C | Spain | 2020Article
Article
Rudnik Schoneborn S ; Thiele S ; Walter MC ; Reinecke L ; Sereda M ; Schoneborn R ; Elbracht M | England | 2020Article
Article
Article
Giannini M ; Grignaschi S ; Fornaro M ; Caporali R ; Locatelli F ; Zanframundo G ; Meyer A ; Montecucco C ; Iannone F ; Paolino S ; Cavagna L | Italy | 12/2019Article
Article
Article
Article
La manifestation clinique la plus fréquente des laminopathies (liées à une mutation dans le gène LMNA) est la cardiomyopathie dilatée arythmogène avec risque de mort subite (MS) par survenue de tachyarythmie ventriculaire (TAV). Le traitement pr[...]Article
Nery FC, Auteur ; Siranosian JJ ; Rosales I ; Deguise MO ; Sharma A ; Muhtaseb AW ; Nwe P ; Johnstone AJ ; Zhang R ; Fatouraei M ; Huemer N ; Alves CRR ; Kothary R ; Swoboda KJ | United States | 08/2019Article
Hackman P ; Savarese M ; Carmignac V ; Udd B ; Salih MA | 11/04/2019Initial Posting: January 12, 2012; Last Update: April 11, 2019. Clinical characteristics. Salih myopathy is characterized by muscle weakness (manifest during the neonatal period or in early infancy) and delayed motor development; children ac[...]